Ampio Pharmaceuticals (AMPE) Fails to deliver data

Key failure to deliver metrics for Ampio Pharmaceuticals:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last 12 months FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Ampio Pharmaceuticals (AMPE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Ampio Pharmaceuticals (AMPE) - since 2023

Ampio Pharmaceuticals (AMPE) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Aerie Pharmaceuticals AERI	N/A	£0.94 M	🇺🇸 USA
Johnson & Johnson JNJ	£54.31 M	£94.31 M	🇺🇸 USA
Flexion Therapeutics FLXN	£0.53 M	£0.54 M	🇺🇸 USA
Rigel Pharmaceuticals RIGL	£0.05 M	£0.67 M	🇺🇸 USA
Abbott Laboratories ABT	£72.42 M	£0.44 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	£5.36 M	£70.47 M	🇺🇸 USA
Pfizer PFE	£24.63 M	£0.10 B	🇺🇸 USA